Alexander Khoruts

University of Minnesota — United States

Medicine · Health Sciences

68h-index23.8kcitations313works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Clostridium difficile and Clostridium perfringens research(154), Gut microbiota and health(140), Gastrointestinal motility and disorders(46), Microscopic Colitis(46), Immune Cell Function and Interaction(29)

Publications312 total

Ongoing lymphoid HIV production drives pyroptosis and GLP-1 counter-regulation in ART-suppressed infection
2026Open Access
Oral rehydration solution for the management of fluid and electrolyte disturbances in patients with an ileostomy: A scoping review
Journal of Parenteral and Enteral Nutrition·2026Open Access
Trial-in-progress: A phase 2 randomized trial of remodeling intestinal microbiota using fecal microbiome transplant (FMT) among recipients of chimeric antigen receptor T cells (CAR T)
Blood·2025
The challenges and opportunities in the expanding horizons of microbiota transplant therapies
Gut Microbes·2025Open Access
The multi-omic basis for hepatic encephalopathy recurrence: Analysis of the THEMATIC trial
JHEP Reports·2025Open Access
S2141 Antibiotic Exposure Is a Short- and Long-Term Risk for Recurrent Clostridioides difficile Infection Following Fecal Microbiota Transplantation
The American Journal of Gastroenterology·2025
P1.11.71 RMT in Non Small Cell Lung Cancer
Journal of Thoracic Oncology·2025
S803 Optimization of Fluid and Electrolyte Status in Adult Patients With Ileostomy
The American Journal of Gastroenterology·2025
S2047 Fecal Microbiota Transplantation Therapy Alters Resistome Burden and Mobilization Potential in a Disease-Dependent Manner
The American Journal of Gastroenterology·2025
Use of proximity ligation shotgun metagenomics to investigate the dynamics of plasmids and bacteriophages in the gut microbiome following fecal microbiota transplantation
Gut Microbes·2025· 3 citedOpen Access
Effect of fecal microbiota transplantation on gut microbiota functional profile in recipients of allogeneic hematopoietic cell transplantation
Gut Microbes·2025· 1 citedOpen Access
Microbiota Transplant Therapy Is Safe and Feasible in Pulmonary Arterial Hypertension
JACC Basic to Translational Science·2025· 2 citedOpen Access
Donor-centric administration of the stool donor program is vital to its feasibility and patient safety
Gut Microbes·2025· 4 citedOpen Access
Impact of the IL-15 superagonist N-803 on lymphatic reservoirs of HIV
JCI Insight·2025· 4 citedOpen Access
Su2006: METABOLOMIC CHANGES AND DONOR ENGRAFTMENT ARE ASSOCIATED WITH REDUCED RECURRENCE OF HEPATIC ENCEPHALOPATHY AFTER FECAL MICROBIOTA TRANSPLANT: THEMATIC RCT ANALYSIS
Gastroenterology·2025
FRI-186 Rifaximin use does not significantly affect the rate of 30-day mortality or liver transplant in patients with cirrhosis on Daptomycin in two national US-based cohorts
Journal of Hepatology·2025
Sa1962: WIDE VARIATIONS IN ANTIMICROBIAL GENE CARRIAGE IN PATIENTS WITH CIRRHOSIS AND HEALTHY CONTROLS FROM 7 COUNTRIES WITH 1020 PARTICIPANTS: IMPLICATIONS FOR RESISTANT INFECTIONS
Gastroenterology·2025Open Access
FMT for Recurrent <i>Clostridioides difficile</i> Infection
Clinical Infectious Diseases·2025· 3 citedOpen Access
Metagenomic source tracking after microbiota transplant therapy
Gut Microbes·2025· 3 citedOpen Access
Rifaximin Does Not Increase the Rate of 30-Day Mortality in Patients With Cirrhosis and Daptomycin in Two National US-Based Cohorts
Gastroenterology·2025· 4 cited
page 1 of 16Next →

Frequent Co-authors

Michael J. Sadowsky(19), Alexa R. Weingarden(9), Christopher Staley(9), Marc K. Jenkins(8), Timothy W. Schacker(6), Matthew J. Hamilton(6), Daniel C. Douek(5), Kathryn A. Pape(5), Gregory J. Beilman(4), Ashley T. Haase(4), Thomas J. Borody(4), Lawrence J. Brandt(4), Colleen Kelly(4), Anna Mondino(4), Johnthomas Kang(4), Stephen C. Jameson(4), Rebecca Merica(3), Courtney V. Fletcher(3), Stephen W. Wietgrefe(3), Cavan Reilly(3)